Literature DB >> 22782511

Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5.

Ying-Zhang Chen1, Mark M Matsushita, Peggy Robertson, Mark Rieder, Santhosh Girirajan, Francesca Antonacci, Hillary Lipe, Evan E Eichler, Deborah A Nickerson, Thomas D Bird, Wendy H Raskind.   

Abstract

BACKGROUND: Familial dyskinesia with facial myokymia (FDFM) is an autosomal dominant disorder that is exacerbated by anxiety. In a 5-generation family of German ancestry, we previously mapped FDFM to chromosome band 3p21-3q21. The 72.5-Mb linkage region was too large for traditional positional mutation identification.
OBJECTIVE: To identify the gene responsible for FDFM by exome resequencing of a single affected individual. PARTICIPANTS: We performed whole exome sequencing in 1 affected individual and used a series of bioinformatic filters, including functional significance and presence in dbSNP or the 1000 Genomes Project, to reduce the number of candidate variants. Co-segregation analysis was performed in 15 additional individuals in 3 generations. MAIN OUTCOME MEASURES: Unique DNA variants in the linkage region that co-segregate with FDFM.
RESULTS: The exome contained 23 428 single-nucleotide variants, of which 9391 were missense, nonsense, or splice site alterations. The critical region contained 323 variants, 5 of which were not present in 1 of the sequence databases. Adenylyl cyclase 5 (ADCY5) was the only gene in which the variant (c.2176G>A) was co-transmitted perfectly with disease status and was not present in 3510 control white exomes. This residue is highly conserved, and the change is nonconservative and predicted to be damaging.
CONCLUSIONS: ADCY5 is highly expressed in striatum. Mice deficient in Adcy5 develop a movement disorder that is worsened by stress. We conclude that FDFM likely results from a missense mutation in ADCY5. This study demonstrates the power of a single exome sequence combined with linkage information to identify causative genes for rare autosomal dominant mendelian diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22782511      PMCID: PMC3508680          DOI: 10.1001/archneurol.2012.54

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  34 in total

Review 1.  Molecular and cellular requirements for the regulation of adenylate cyclases by calcium.

Authors:  D M F Cooper
Journal:  Biochem Soc Trans       Date:  2003-10       Impact factor: 5.407

Review 2.  Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation.

Authors:  J U Linder
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

3.  Distribution and intensity of constraint in mammalian genomic sequence.

Authors:  Gregory M Cooper; Eric A Stone; George Asimenos; Eric D Green; Serafim Batzoglou; Arend Sidow
Journal:  Genome Res       Date:  2005-06-17       Impact factor: 9.043

4.  Population analysis of large copy number variants and hotspots of human genetic disease.

Authors:  Andy Itsara; Gregory M Cooper; Carl Baker; Santhosh Girirajan; Jun Li; Devin Absher; Ronald M Krauss; Richard M Myers; Paul M Ridker; Daniel I Chasman; Heather Mefford; Phyllis Ying; Deborah A Nickerson; Evan E Eichler
Journal:  Am J Hum Genet       Date:  2009-01-22       Impact factor: 11.025

5.  Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals.

Authors:  J Buck; M L Sinclair; L Schapal; M J Cann; L R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

Review 6.  The effects of stress on central dopaminergic neurons: possible clinical implications.

Authors:  J M Finlay; M J Zigmond
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

7.  Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder.

Authors:  M Fernandez; W Raskind; J Wolff; M Matsushita; E Yuen; W Graf; H Lipe; T Bird
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

8.  Motor dysfunction in type 5 adenylyl cyclase-null mice.

Authors:  Tamio Iwamoto; Satoshi Okumura; Kousaku Iwatsubo; Jun-Ichi Kawabe; Koji Ohtsu; Ikuko Sakai; Yoko Hashimoto; Aki Izumitani; Kazunori Sango; Kyoko Ajiki; Yoshiyuki Toya; Satoshi Umemura; Yoshio Goshima; Nobutaka Arai; Stephen F Vatner; Yoshihiro Ishikawa
Journal:  J Biol Chem       Date:  2003-03-28       Impact factor: 5.157

9.  Stress-induced increase of extracellular levels of cyclic AMP in rat cortex.

Authors:  E A Stone; S M John
Journal:  Brain Res       Date:  1992-11-27       Impact factor: 3.252

Review 10.  The neurobiology of dopamine signaling.

Authors:  Jean-Antoine Girault; Paul Greengard
Journal:  Arch Neurol       Date:  2004-05
View more
  54 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

2.  Functional characterization of AC5 gain-of-function variants: Impact on the molecular basis of ADCY5-related dyskinesia.

Authors:  T B Doyle; M P Hayes; D H Chen; W H Raskind; V J Watts
Journal:  Biochem Pharmacol       Date:  2019-02-14       Impact factor: 5.858

Review 3.  Genetic Dystonias: Update on Classification and New Genetic Discoveries.

Authors:  Ignacio Juan Keller Sarmiento; Niccolò Emanuele Mencacci
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-09       Impact factor: 5.081

4.  Child Neurology: Spastic paraparesis and dystonia with a novel ADCY5 mutation.

Authors:  Marissa Dean; Ludwine Messiaen; Gregory M Cooper; Michelle D Amaral; Salman Rashid; Bruce R Korf; David G Standaert
Journal:  Neurology       Date:  2019-09-10       Impact factor: 9.910

Review 5.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

6.  Adenylate cyclase 1 (ADCY1) mutations cause recessive hearing impairment in humans and defects in hair cell function and hearing in zebrafish.

Authors:  Regie Lyn P Santos-Cortez; Kwanghyuk Lee; Arnaud P Giese; Muhammad Ansar; Muhammad Amin-Ud-Din; Kira Rehn; Xin Wang; Abdul Aziz; Ilene Chiu; Raja Hussain Ali; Joshua D Smith; Jay Shendure; Michael Bamshad; Deborah A Nickerson; Zubair M Ahmed; Wasim Ahmad; Saima Riazuddin; Suzanne M Leal
Journal:  Hum Mol Genet       Date:  2014-01-29       Impact factor: 6.150

7.  The emerging role of genomics in the diagnosis and workup of congenital urinary tract defects: a novel deletion syndrome on chromosome 3q13.31-22.1.

Authors:  Anna Materna-Kiryluk; Krzysztof Kiryluk; Katelyn E Burgess; Arkadiusz Bieleninik; Simone Sanna-Cherchi; Ali G Gharavi; Anna Latos-Bielenska
Journal:  Pediatr Nephrol       Date:  2013-11-30       Impact factor: 3.714

8.  Altered splicing of ATP6AP2 causes X-linked parkinsonism with spasticity (XPDS).

Authors:  Olena Korvatska; Nicholas S Strand; Jason D Berndt; Tim Strovas; Dong-Hui Chen; James B Leverenz; Konstantin Kiianitsa; Ignacio F Mata; Emre Karakoc; J Lynne Greenup; Emily Bonkowski; Joseph Chuang; Randall T Moon; Evan E Eichler; Deborah A Nickerson; Cyrus P Zabetian; Brian C Kraemer; Thomas D Bird; Wendy H Raskind
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

Review 9.  Update on the Genetics of Dystonia.

Authors:  Katja Lohmann; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

10.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.